USPTO 2015–2025 USPTO PatentsView US Corporation

Ablexis, LLC

USPTO PatentsView assignee record - 23 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ablexis ranks #12,778 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 3 technology areas.

#12,778
of 49,997 US assignees by volume
31st percentile
by Innovation Score (29.6/100)
18.2
avg claims per patent
+375%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12778 · US Corporation #12,778 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 23 grants
  • MID-PACK #12,778/49,997
  • PHOTO-FINISH 1QB Information
  • CPC-NARROW C07K · 3 areas
  • INNOV-THIN 29.6/100
  • CLAIMS-RICH 18.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +375% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1QB Information Technologies Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ablexis’s 29.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ablexis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ablexis's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ablexis?

Each dot is one of Ablexis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ablexis’s own 18.2 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ablexis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 22.52323.52424.5 51015202530 Granted patents (volume) Avg claims / patent Zyno Medical, LLC - 24, 16.04Zyno MedicaliBasis, Inc. - 24, 27.33ibasisolloclip, LLC - 24, 9olloclip1QB Information Technologies Inc. - 23, 21.481QB InformationABM International, Inc. - 23, 13.61ABM InternationalAcceleware Ltd. - 23, 22.83AccelewareAdac Plastics, Inc. - 23, 18.61Adac PlasticsADDUP - 23, 10.78AddupAblexis, LLC - 23, 18.17Ablexis
Ablexis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ablexis's grants concentrate

Ablexis, LLC is a focused PatentsView assignee: 3 CPC subclasses with 95.7% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (13 grants) versus a trough of 1 in 2016. By volume, Ablexis sits between Zyno Medical, LLC and ADDUP.

Ablexis's three-year grant acceleration

Ablexis, LLC shows 4 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ablexis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ablexis holds 23 patents at rank #12,778, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ablexis

By rank, the assignees closest to #12,778 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Ablexis's primary technology class.

Ablexis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2016201720192020202120222023 1
USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Ablexis, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 4.3%
2017 1 4.3%
2019 2 8.7%
2020 13 56.5%
2021 2 8.7%
2022 3 13.0%
2023 1 4.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ablexis, LLC's patent record in context - here's where to go next.

  • Ablexis, LLC's lead technology class is C07K (Peptides), 95.7% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #12,778 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ablexis, LLC against Zyno Medical, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.